Phase I clinical trial of mafosfamide in infants and children aged 3 years or younger with newly diagnosed embryonal tumors: a pediatric brain tumor consortium study (PBTC-001).

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples